References
1. Cariban, Summary of Product Characteristics (SPC). June 2026
2. Hyperemesis and Nausea/Vomiting In Pregnancy Guidelines. Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and the Clinical Strategy and Programmes Division, Health Service Executive. 2018.
3. Cariban, Patient Information Leaflet (PIL). May 2026
4. Campbell K, Rowe H, Azzam H, Lane CA. The Management of Nausea and Vomiting of Pregnancy. J Obstet Gynaecol Can. 38(12):1127-37. 2016
5. Madjunkova, Svetlana et al. “The delayed-release combination of doxylamine and pyridoxine (Diclegis®/Diclectin ®) for the treatment of nausea and vomiting of pregnancy.” Paediatric drugs vol. 16,3 (2014): 199-211. doi:10.1007/s40272-014-0065-5
6. Gadsby R, et al. Nausea and vomiting of pregnancy and resource implications: the NVP Impact Study. British Journal of General Practice 2019; 69 (680): e217-e223. DOI: https://doi.org/10.3399/bjgp18X700745
Ensure you are viewing relevant content
Please select from the following options:
MAT-CARI-IE-000081
MAT-CARI-IE-000082
|
Date of preparation: August 2025